$ABT News

Assessing Abbott Laboratories (ABT) Valuation After New Diabetes Sensor And Cancer Screening Tailwinds

MiniMed expands Abbott partnership to add dual glucose-ketone sensor

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor

MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott

How A Steady Valuation Is Shaping The Evolving Abbott Laboratories (ABT) Investment Story

Why Investors Are Cautious on Abbott Laboratories (ABT)?

The demand for healthcare is going to continue to accelerate, says Abbott Labs CEO Robert Ford

Abbott's CE Mark Win for Libre Duo Systems May Lift Its Stock

Is ACS’s Cologuard Endorsement Reshaping the Investment Case for Abbott Laboratories (ABT)?

BSX vs. ABT: Which Medical Stock Has More Upside Potential?

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Is Abbott Laboratories Stock Underperforming the Dow?

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

Abbott obtains CE mark for duo of glucose-ketone monitors

Abbott (ABT) Wins FDA and EU Approval for an AI-Powered Tool That Guides Artery Stent Placement

Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

Abbott Receives CE Mark For Its Dual Glucose-Ketone Sending Technology For Diabetes Patients